(HealthDay News) — Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct. 1 in BMJ Quality & Safety.

The US Department of Health and Human Services has set a goal that at least 95% of children in kindergarten get 2 doses of the measles-mumps-rubella (MMR) vaccine, a threshold that helps prevent ...

The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.

The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum glucocorticoid regulated kinase 1 (SGK1) inhibitor, for the treatment of long QT syndrome ...

Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to navenibart for the treatment of hereditary angioedema (HAE).

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of breast ...

In what could be the first cases of bird flu between humans in the US, a group of potential H5N1 infections in Missouri has now grown to 8.

The Food and Drug Administration (FDA) has granted Fast Track designation to zilganersen for the treatment of Alexander disease, a rare type of leukodystrophy.

HealthDay News — Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70% of women with gestational diabetes mellitus (GDM), according to a study published online September 18 ...

The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for sepiapterin as a treatment for pediatric and adult patients living with phenylketonuria (PKU).